Cervical plexus block as an alternative anesthetic approach for type I thyroplasty: a case report / Bloqueio do plexo cervical como técnica anestésica alternativa para tireoplastia tipo I: relato de caso

Abstract Background: The role of type I thyroplasty (TIP) is well established as the treatment for glottal insufficiency due to vocal fold paralysis, but the ideal anesthetic management for this procedure is still largely debated. We present the case of a novel anesthetic approach for TIP using combined intermediate and superficial Cervical Plexus Block (CPB) and intermittent mild sedation analgesia. Case report: A 51-year-old presenting with left vocal fold paralysis and obstructive sleep apnea was scheduled for TIP. An ultrasound-guided intermediate CPB was performed using the posterior approach, and 15 mL of ropivacaine 0.5% were injected in the posterior cervical space between the sternocleidomastoid muscle and the prevertebral fascia. Then, for the superficial CPB, a total of 10 mL 0.5% ropivacaine was injected subcutaneously, adjacently to the posterior border of the sternocleidomastoid muscle, without penetrating the investing fascia An intermittent sedation analgesia with a target-controlled infusion of remifentanyl (target 0.5 ng.mL-1) was used to facilitate prosthesis insertion and the fiberoptic laryngoscopy. This technique offered a safe anesthetic airway and good operating conditions for the surgeon, as well as feasible voice monitoring and optimal patient comfort. Conclusion: The use of a regional technique is a promising method for the anesthetic management in TIP, especially in patients with compromised airway.

Resumo Introdução: O papel da tireoplastia tipo I (TPI) está bem estabelecido no tratamento de insuficiência glótica após a paralisia das pregas vocais, mas o manejo anestésico ideal para a TPI ainda é controverso. Descrevemos uma nova técnica anestésica para a TPI usando o Bloqueio do Plexo Cervical (BPC) superficial e o BPC intermediário associados, em presença de analgo-sedação leve e intermitente. Relato de caso: Paciente de 51 anos de idade com paralisia da prega vocal esquerda e apneia obstrutiva do sono foi agendada para TPI. BPC intermediário guiado por ultrassom foi realizado usando acesso posterior, e 15 mL de ropivacaína a 0,5% foram injetados no espaço cervical posterior entre o músculo esternocleidomastoideo e a fáscia prevertebral. A seguir, para o BPC superficial, 10 mL de ropivacaína a 0,5% foram injetados na região subcutânea adjacente à borda posterior do músculo esternocleidomastoideo, sem transfixar a fáscia de revestimento. Analgo-sedação intermitente com infusão alvo-controlada de remifentanil (alvo de 0,5 ng.mL-1) foi usada para facilitar a inserção da prótese e a laringoscopia com fibra ótica. A técnica ofereceu via aérea segura durante a anestesia, boa condição para o cirurgião, possibilidade de monitorar a voz, além de ótimo conforto à paciente. Conclusões: O uso de anestesia regional é uma técnica promissora para o cuidado anestésico durante a TPI, especialmente em pacientes com via aérea comprometida.

Parálisis de cuerda vocal secundaria a intubación endotraqueal y su manejo: revisión en relación a dos casos clínicos / Vocal cord paralysis secondary to endotracheal intubation and its management: review in relation to two clinical cases

La parálisis de cuerda vocal secundaria a intubación endotraqueal es una complicación poco frecuente de la anestesia general. Se manifiesta con disfonía precoz luego de la extubación, y en ocasiones se asocia a aspiración. A continuación se presenta el reporte de dos pacientes sometidos a cirugía abdominal con anestesia general e intubación endotraqueal, que presentan una parálisis cordal unilateral en el posoperatorio inmediato. En ambos pacientes se realiza una laringoplastía de inyección con ácido hialurónico (Restylane®), con buenos resultados vocales. Uno de los casos tiene seguimiento a lo largo de dos años. Se describe esta patología y su manejo mediante una revisión bibliográfica.

Vocal fold paralysis posterior to endotracheal intubation is a very uncommon complication of the general anestesia. The symptoms includes hoarseness posterior to the extubation, and some times aspiration occurs. In this paper we present the report of two cases of abdominal surgery with general anesteshia and endotraqueal intubation procedures. Both subjects developed unilateral vocal fold paralysis after the process. The patients were treated with wedilization injection with Restylane ®, satisfactory voice's results were achieved. One of them has an observational time of two years. We describe this infrequent pathology and the treatment through literature review.

Laringoplastía de inyección con ácido hialurónico, experiencia del Hospital Clínico de la Pontificia Universidad Católica de Chile / Laryngoplasty injection with hyaluronic acid, Hospital Clinico de la Pontificia Universidad Catolica de Chile experience

Introducción: El manejo inicial de la parálisis cordal unilateral incluye la observación en espera de la recuperación de la movilidad o la compensación, terapia fonoaudiológica o inyección de medialización temporal para llevar la cuerda a una posición más favorable para el cierre glótico. Este procedimiento puede realizarse en pabellón, o vía percutánea en paciente despierto. Existen varias opciones, siendo el ácido hialurónico (Restylane®) uno de los más usados. Objetivo: Revisar la experiencia pionera en el país en la inyección de medialización de cuerda vocal con ácido hialurónico en el manejo de la parálisis cordal unilateral. Material y método: Estudio retrospectivo, que incluyó a 15 pacientes con insuficiencia glótica a los que se les realizó una inyección percutánea con ácido hialurónico. Se evaluó la calidad de la voz pre y posprocedimiento (VRQOL), tolerancia al procedimiento y complicaciones. Resultados: El 100% de los pacientes mostró cambios significativos en el VRQOL, con un cambio promedio pre y post de 37%. El procedimiento fue bien tolerado en el 93%. No se produjeron incidentes durante la inyección ni tampoco posteriores. Conclusión: La inyección de medialización es un procedimiento bien tolerado, seguro y sencillo, que permite mejoras significativas en la calidad vocal. El ácido hialurónico es seguro y eficaz para la inyección de medialización.

Introduction: Initial treatment options for unilateral vocal fold paralysis include observation for spontaneous return of function or compensation, voice therapy to stimulate recovery of motion or function, or temporary vocal fold injection medialization to improve glottic closure. Temporary injection medialization can be performed under general anesthesia or in the awake-patient setting with local anesthesia. There are different options of temporary injection materials, being hyaluronic acid (Restylane®) one of the most popular. Aim: To review our pioneer experience in Chilewith the use of temporary vocal fold injection with hyaluronic acid in the initial management of unilateral vocal fold paralysis. Material and method: Retrospective study involving 15 patients with glottic insufficiency, who underwent percutaneous vocal fold injection medialization with hyaluronic acid. Pre and post procedure quality of voice (VRQOL), tolerance to the procedure, and complications were evaluated. Results: All patients showed significant changes in VRQOL, with a 37% average improvement. The procedure was well tolerated in 93%. No incidents occurred during injection orlater. Conclusions: The temporary vocal fold injection medialization is a well-tolerated, safe and simple procedure that allows significant short-term improvements in vocal quality of patients. Hyaluronic acid is a safe and effective material for temporary vocal foldinjection medialization.

Cardiac troponin and C-reactive protein for predicting all-cause and cardiovascular mortality in patients with chronic kidney disease: A meta-analysis

Elevated serum levels of cardiac troponin and C-reactive protein are associated with all-cause and cardiovascular mortality in patients with end-stage renal disease. However, the relationship between these two biomarker levels and mortality in patients with chronic kidney disease remains unclear. We conducted a meta-analysis to quantify the association of cardiac troponin and C-reactive protein levels with all-cause and cardiovascular mortality in patients with chronic kidney disease. Relevant studies were identified by searching the MEDLINE database through November 2013. Studies were included in the meta-analysis if they reported the long-term all-cause or cardiovascular mortality of chronic kidney disease patients with abnormally elevated serum levels of cardiac troponin or C-reactive protein. Summary estimates of association were obtained using a random-effects model. Thirty-two studies met our inclusion criteria. From the pooled analysis, cardiac troponin and C-reactive protein were significantly associated with all-cause (HR 2.93, 95% CI 1.97-4.33 and HR 1.21, 95% CI 1.14-1.29, respectively) and cardiovascular (HR 3.27, 95% CI 1.67-6.41 and HR 1.19, 95% CI 1.10-1.28, respectively) mortality. In the subgroup analysis of cardiac troponin and C-reactive protein, significant heterogeneities were found among the subgroups of population for renal replacement therapy and for the proportion of smokers and the C-reactive protein analysis method. Elevated serum levels of cardiac troponin and C-reactive protein are significant associated with higher risks of all-cause and cardiovascular mortality in patients with chronic kidney disease. Further studies are warranted to explore the risk stratification in chronic kidney disease patients.

Balloon laryngoplasty for acquired subglottic stenosis in children: predictive factors for success / Laringoplastia com balão para estenose sub-glótica adquirida na infância: fatores preditivos de sucesso / Laringoplastia com balão para estenose sub-glótica adquirida na infância: fatores preditivos de sucesso

INTRODUCTION: The treatment of subglottic stenosis in children remains a challenge for the otorhinolaryngologist, and may involve both endoscopic and open surgery. OBJECTIVE: To report the experience of two tertiary facilities in the treatment of acquired subglottic stenosis in children with balloon laryngoplasty, and to identify predictive factors for success of the technique and its complications. METHODS: Descriptive, prospective study of children diagnosed with acquired subglottic stenosis and submitted to balloon laryngoplasty as primary treatment. RESULTS: Balloon laryngoplasty was performed in 37 children with an average age of 22.5 months; 24 presented chronic subglottic stenosis and 13 acute subglottic stenosis. Success rates were 100% for acute subglottic stenosis and 32% for chronic subglottic stenosis. Success was significantly associated with acute stenosis, initial grade of stenosis, children of a smaller age, and the absence of tracheostomy. Transitory dysphagia was the only complication observed in three children. CONCLUSION: Balloon laryngoplasty may be considered the first line of treatment for acquired subglottic stenosis. In acute cases, the success rate is 100%, and although the results are less promising in chronic cases, complications are not significant and the possibility of open surgery remains without prejudice. .

INTRODUÇÃO: O tratamento das estenoses subglóticas em crianças ainda representa um desafio para o otorrinolaringologista, e pode envolver tanto procedimentos endoscópicos quanto cirurgias reconstrutivas abertas. OBJETIVO: Apresentar a experiência de dois serviços terciários no manejo das estenoses subglóticas adquiridas em crianças, através da laringoplastia com balão e identificar fatores preditivos de sucesso e as complicações. MÉTODO: Estudo descritivo prospectivo de crianças com estenose subglótica adquirida submetidas à laringoplastia com balão como tratamento primário. RESULTADOS: Foram incluídas 37 crianças (média de idade 22,5 meses): 24 crianças portadoras de estenose subglótica crônica e 13 de estenose subglótica aguda. A taxa de sucesso do tratamento foi de 100% para os casos agudos e 32% para os casos crônicos. O sucesso do tratamento teve correlação significativa com: tempo de evolução da estenose, grau inicial da estenose, menor idade das crianças e a ausência de traqueostomia prévia. Disfagia transitória foi a única complicação observada em três pacientes. CONCLUSÃO: A laringoplastia com balão pode ser considerada como primeira linha de tratamento nas estenoses subglóticas. Nos casos agudos a taxa de sucesso é de 100% e o ganho, mesmo que parcial nos casos crônicos, é insento de complicações significativas e não traz prejuízo para cirurgias reconstrutivas posteriores. .

Laringoplastía con interposición de cartílago del ala del tiroides en pacientes adultos / Laryngoplasty with interposition of cartilage thyroid wing in adult patients

Establecer la estabilidad y resistencia del cartílago tiroideo para la ampliación de la subglotis en pacientes estenosados, y comparar los resultados funcionales entre laringoplastías con cartílago de ala tiroidea y cartílago costal. Diseño: estudio comparativo retrospectivo. Método: desde 2003 al 2010, se realizaron laringoplastías con interposición de cartílago a 17 pacientes con estenosis subglótica. Los mismos se distribuyeron en dos grupos: grupo A: 7 pacientes operados con laringoplastía e interposición de cartílago del ala del tiroides; grupo B: grupo control de 10 pacientes con laringoplastía e interposición de cartilago costal. Los puntos de análisis fueron las complicaciones intra y post quirúrgicas, y el éxito de la técnica quirúrgica logrado al decanular al paciente. Resultado: en el grupo A (ala tiroidea) la complicación más frecuente fue la disnea, ya sea temprana, la cual se presentó en el 42% de los pacientes por obstrucción del stent con tapón mucoso; o bien tardías en el 57% de los casos debido a el desarrollo de granulomas. En ambos casos se realizó abordaje endoscópico y corticoides sistémico. En el grupo B (cartilago costal) la disnea temprana se presento en el 10% de los pacientes, mientras que la tardía por granulomas se hizo presente en el 20% de los casos. Así también se presento un caso de neumotórax intraoperatorio el cual se resolvió inmediatamente de forma quirúrgica. Conclusión: el uso del cartílago del ala tiroidea en las laringoplastías por estenosis, permite una ampliación del diámetro subglótico tan segura como la que se ha comprobado con el cartílago costal. El cartílago del ala tiroidea es un injerto con un grosor suficiente, capaz de mantener la estructura de la vía aérea sin alterar la función laríngea y acortando los tiempos quirúrgicos con respecto a la obtención e interposición del cartílago costal...

To establish the stability and resistance of the thyroid ala cartilage to expand adult's subglottis stenosis, and to compare the functional results between laringoplastias with thyroid ala cartilage (TAC) and costal cartilage (CC) graft. Design: Retrospective comparative study. Method: 17 patients with subglottic stenosis were operated using cartilage interposition graft from 2003 to 2010. They were divided into two groups: group A: 7 patients with anterior laryngoplasty using thyroid ala cartilage - group B: control group of 10 patients with laryngoplasty and interposition of costal cartilage. The analysis points were intra and post surgical complications, and the success of the surgical procedure following the patient's decannulation. Results: Group A (TAC) the most frequent complication was dyspnea which appeared at an early stage in 42% of patients with mucus plug stent obstruction, or dyspnea either appeared at a later stage in 57% of the cases due to the development of granulation tissue. In both cases endoscopic approach and systemic corticosteroids were performed. Group B (costal cartilage) complications: early dyspnea appeared in 10% of patients, while dyspnea at a later stage due to granulomas appeared in 20% of cases. An intraoperative pneumothorax complication occurred and was resolved immediately. Conclusion: The use of thyroid ala cartilage graft in laryngeal stenosis allows an expansion of subglottic diameter as sale as it has been verified with the use of costal cartilage. The thyroid ala cartilage graft is thick enough to keep the airway structure preserving laryngeal function and shortening surgical time in comparison to the costal cartilage technique...

Comparação do uso de implante de Silastic(r) com titânio pré-fabricado na tireoplastia tipo I / Comparison of the use of silastic with titanium prefabricated implant in type I thyroplasty

Introdução: A tireoplastia tipo I é o tratamento de escolha nas paralisias unilaterais das pregas Análise de custo-bene-vocais que não se recuperam espontaneamente. fício. Objetivos: Comparar o uso de implante de Silastic® com o uso de titânio pré-fabricado TVFMI® (Titanium Vocal Fold Medializing Implant) na tireoplastia tipo I para o tratamento da paralisia unilateral das pregas vocais com relação à melhora subjetiva e objetiva da voz, às alterações endoscópicas nas pregas vocais, ao tempo de cirurgia e à relação custo-benefício. Método: Trata-se de um estudo prospectivo com 40 pacientes portadores de paralisia unilateral das pregas vocais submetidos à tireoplastia tipo I com implante de silastic® ou TVFMI®. A avaliação e comparação estatística foram realizadas antes e quatro semanas depois da cirurgia por meio de videolaringoscopia, estroboscopia, análise perceptiva (escala GRBAS-Grade, Roughness, Breathiness, Asthenia, Strain) e subjetiva (IDV-índice de desvantagem vocal) da voz e avaliação eletroglotográfica e avaliação acústica computadorizada. Também foram observados o tempo de cirurgia e o custo do implante. Resultados: Embora os dois implantes mostrem melhora na qualidade da voz após a tireoplastia, o TVFMI® teve um resultado ligeiramente melhor na análise objetiva da voz. O TVFMI® levou menos tempo de cirurgia para ser inserido, porém foi mais caro. Conclusão: O TVFMI® poderá ser preferencial na tireoplastia de medialização, já que possui melhores resultados vocais e leva menos tempo de cirurgia, porém é mais caro que o implante de Silastic®. .

Introduction: Type I thyroplasty is the treatment of choice for unilateral vocal cord palsy with no spontaneous recovery. Objectives: To compare the use of silastic implant with titanium vocal fold medializing implant (TVFMI®) in type I thyroplasty for unilateral vocal cord palsy with respect to subjective and objective improvement in voice, endoscopic changes in vocal cords, surgical time, and cost effectiveness. Methodology: This was a prospective study conducted on 40 patients with unilateral vocal cord paralysis who underwent type I thyroplasty with either silastic implant or TVFMI®. Pre-operative and four-week post-operative assessment and statistical comparison were performed by videolaryngoscopy, stroboscopy, perceptual assessment (GRBAS), subjective (voice handicap index) analysis of voice, and computer-assisted acoustic and electroglottographic assessment. The duration of surgery and cost of implant were also recorded. Results: Although both implants showed improvement in quality of voice following thyroplasty, TVFMI® presents slightly better results in objective voice analysis. The surgery time for TVFMI®insertion was shorter, but the costs were higher. Conclusion: TVFMI® may be preferred for medialization thyroplasty as it presents better voice results and demands less surgical time; however, it is costlier than silastic implant. .

Autologous Platelet-Poor Plasma Gel for Injection Laryngoplasty

PURPOSE: To overcome the potential disadvantages of the use of foreign materials and autologous fat or collagen, we introduce here an autologous plasma gel for injection laryngoplasty. The purpose of this study was to present a new injection material, a plasma gel, and to discuss its clinical effectiveness. MATERIALS AND METHODS: From 2 mL of blood, the platelet poor serum layer was collected and heated at 100degrees C for 12 min to form a plasma gel. The plasma gel was then injected into a targeted site; the safety and efficacy thereof were evaluated in 30 rats. We also conducted a phase I/II clinical study of plasma gel injection laryngoplasty in 11 unilateral vocal fold paralysis patients. RESULTS: The plasma gel was semi-solid and an easily injectable material. Of note, plasma gel maintains the same consistency for up to 1 year in a sealed bottle. However, exposure to room air causes the plasma gel to disappear within 1 month. In our animal study, the autologous plasma gel remained in situ for 6 months in animals with minimal inflammation. Clinical study showed that vocal cord palsy was well compensated for with the plasma gel in all patients at two months after injection with no significant complications. Jitter, shimmer, maximum, maximum phonation time (MPT) and mean voice handicap index (VHI) also improved significantly after plasma gel injection. However, because the injected plasma gel was gradually absorbed, 6 patients needed another injection, while the gel remained in place in 2 patients. CONCLUSION: Injection laryngoplasty with autologous plasma gel may be a useful and safe treatment option for temporary vocal cord palsy.

Laringoplastia com balão em crianças com estenose subglótica em evolução: experiência de um hospital terciário / Balloon laryngoplasty in children with acute subglottic stenosis: experience of a tertiary-care hospital

O manejo da estenose subglótica (ESG) em crianças continua sendo um desafio para os otorrinolaringologistas. A laringoplastia com balão (LPB) consiste num procedimento endoscópico, descrito inicialmente em 1984, para tratamento de estenoses da via aérea alta, apresentando várias vantagens em relação a outras técnicas cirúrgicas e com resultados promissores. OBJETIVO: Apresentar a nossa experiência com a realização de LPB em pacientes pediátricos com ESG. MATERIAL E MÉTODO: Estudo prospectivo de pacientes pediátricos com diagnóstico de ESG pós-extubação em evolução (ainda com tecido de granulação). Realizou-se laringoscopia direta sob anestesia geral e dilatação do segmento estenótico com cateter de angioplastia. Os pacientes foram acompanhados e nova laringoscopia foi realizada uma semana após o procedimento inicial. RESULTADOS: Foram incluídas no estudo oito crianças no período de junho de 2009 a outubro de 2010. Destas, quatro apresentavam ESG Grau 3, três apresentavam ESG Grau 2 e uma, ESG Grau 1. Na laringoscopia direta de revisão, apenas duas apresentavam ESG residual assintomática (Grau 1), sendo que as outras seis apresentavam via aérea normal e estavam assintomáticas. CONCLUSÃO: A LPB parece ser um tratamento efetivo para ESG em evolução. Necessitamos mais estudos para sabermos a eficácia, a segurança e as indicações deste procedimento.

Management of subglottic stenosis (SGS) in children is still a challenge to Otorhinolaryngologists. Balloon laryngoplasty (BLP) is an endoscopic procedure, first described in 1984 for the treatment of airway stenosis. It shows promising results and seems to be more effective than other procedures. AIM: To present our experience with BLP in children with SGS. MATERIAL AND METHOD: Prospective study of children diagnosed with acute subglottic stenosis, i.e., stenosis with granulation tissue. They underwent direct laryngoscopy under general anesthesia and dilatation of the stenotic segment with angioplasty balloon. They were followed up and a second laryngoscopy was performed one week later. RESULTS: Eight children were included in this study between June 2009 and October 2010. Four had Grade 3 SGS, three had Grade 2 SGS and one had Grade 1 SGS. By the second examination, two children presented with asymptomatic Grade 1 SGS, while the other six presented with normal airway and remained asymptomatic. CONCLUSION: BLP seems to be an effective treatment for acute SGS. We need more studies to refine our knowledge concerning efficacy rates, safety and indications for balloon dilatation.